TRESIVAC® VACCINE — ESSENTIAL TRIPLE PROTECTION (MMR)

Tresivac is a high-precision, live-attenuated vaccine specifically engineered to provide concurrent immunity against three major viral diseases: Measles, Mumps, and Rubella (MMR). It contains weakened strains of these viruses which, when administered, stimulate the body’s immune system to produce protective antibodies without causing the diseases themselves. This "triple-action" vaccine is a cornerstone of global pediatric health, designed to prevent the severe complications associated with these viruses, such as pneumonia, brain inflammation (encephalitis), deafness, and congenital rubella syndrome in unborn children.

• Product Type: Live-Attenuated Viral Vaccine (Lyophilized)

• Active Components: Measles (Edmonston-Zagreb strain), Mumps (L-Zagreb strain), and Rubella (Wistar RA 27/3 strain)

• Manufacturer: Serum Institute of India (SII)

• Form: Freeze-dried powder (must be reconstituted with provided sterile diluent)

• Route: Subcutaneous (SC) Injection Only

• Availability: Prescription/Clinic Use Only — Administered by healthcare professionals

• Suitable For: Children (from 9–12 months) and non-immune adults

What Is Tresivac Used For?

Tresivac is a foundational vaccine used to eliminate the risk of highly contagious viral outbreaks:

1. Measles Prevention: Protecting against high fever, severe rash, and life-threatening complications like blindness or pneumonia.

2. Mumps Prevention: Preventing painful swelling of the salivary glands and complications like orchitis (inflammation of the testes) or meningitis.

3. Rubella (German Measles) Prevention: Essential for stopping the spread of Rubella, which can cause devastating birth defects if a pregnant woman is infected.

4. Outbreak Control: Providing rapid community immunity in schools and daycare settings.

⚠️ Critical Safety Warning

Pregnancy: Tresivac is a live vaccine and must NOT be given to pregnant women. Women should avoid becoming pregnant for at least one month after receiving the vaccine. Immune Deficiency: Do not administer to individuals with severe immune suppression (e.g., advanced HIV, leukemia, or those on high-dose steroids). Egg Allergy: While many children with mild egg allergies can safely receive MMR, those with a history of anaphylaxis to eggs or Neomycin must be evaluated by a specialist first. Recent Blood Products: If the patient has recently received a blood transfusion or human immunoglobulin, the vaccination should be delayed by 3–11 months, as these can neutralize the vaccine.

Immunization Schedule

For lifelong protection, a two-dose series is highly recommended by the World Health Organization (WHO) and the Nigerian National Programme on Immunization (NPI).

Standard 2-Dose Schedule:

• 1st Dose: Typically administered at 9 to 12 months of age.

• 2nd Dose: Typically administered at 15 to 18 months (or up to 4–6 years of age).

Application Tips:

• Professional Administration: Tresivac must be injected by a trained nurse or doctor, usually into the fatty tissue of the upper arm.

• Immediate Use: Once the powder is mixed with the diluent (reconstituted), it must be used immediately or stored in the dark at 2°C–8°C and discarded within 6 hours.

• Fever Management: It is common for a mild fever or slight rash to appear 7 to 10 days after the injection. This is the body building its immune response.

Common Side Effects

Most side effects are mild and transient. These include soreness at the injection site, a low-grade fever, or a faint "measles-like" rash about a week after the dose. Rarely, temporary joint pain (especially in adult women) or a temporary low platelet count may occur. If the patient develops a very high fever, seizure, or signs of an allergic reaction (hives/difficulty breathing), seek emergency care immediately.

Storage & Cold Chain Management

• Refrigeration Required: The vaccine powder must be stored between 2°C and 8°C.

• Freeze Protection: The sterile diluent (liquid) should not be frozen.

• Light Sensitivity: Tresivac is highly sensitive to light; it must be kept in its original carton until the moment of reconstitution.

• Cold Chain Integrity: Sanlive Pharmacy utilizes 24/7 monitored medical refrigeration to ensure the live viruses remain viable and effective for your family.

Frequently Asked Questions (FAQ)

Q: Does the MMR vaccine cause "Autism"?

A: No. Extensive, high-quality global research involving millions of children has proven there is no link between the MMR vaccine and autism. This was a result of fraudulent data that has been thoroughly debunked.

Q: Can adults take Tresivac?

A: Yes. Adults who were never vaccinated or never had these diseases as children should receive at least one dose, especially before traveling or starting work in healthcare.

Q: Can I get this vaccine if I have a "Cold"?

A: If it is a minor cold without a fever, you can usually proceed. If there is a moderate-to-high fever, it is better to wait until the patient is recovered.

Q: Why do they need a "Second Dose"?

A: The first dose protects about 93% of people. The second dose is a "booster" to ensure the remaining 7% develop full immunity.

Purchase & Administration Notice at Sanlive Pharmacy

Authentic Tresivac (MMR) Vaccine is available through Sanlive Pharmacy. As a Cold-Chain product, we provide specialized delivery to healthcare facilities. We can also assist you in tracking your child's immunization record to ensure the second dose is given at the optimal time.

Why Choose Sanlive Pharmacy for Vaccines?

• Authentic Serum Institute of India (SII) stock with verifiable batch integrity.

• Strict 24/7 Cold Chain temperature monitoring and backup power.

• Expert pediatric guidance on the Nigerian NPI immunization schedule.

• Reliable, temperature-controlled delivery within Lagos and across Nigeria.

Order Tresivac from Sanlive Pharmacy today to provide your child with lifetime protection against Measles, Mumps, and Rubella.